KEY POINTS
  • Procter & Gamble said it appointed Nelson Peltz to its board despite the activist investor narrowly losing a months-long proxy fight.
  • The boardroom battle was the biggest ever involving a U.S. company.
  • The consumer goods conglomerate said it increased its board size by 2 to 13 - to accommodate Peltz and appoint a new director in Joseph Jimenez, CEO of drugmaker Novartis.
Nelson Peltz

Procter & Gamble said it appointed Nelson Peltz to its board despite the activist investor narrowly losing a months-long proxy fight, the biggest ever involving a U.S. company.

The company's shares were up 1 percent in after-market trading on Friday.